ArticleClinical medicine insights. Case reports2026
Miller-Fisher Syndrome Presenting With Severe Headache and Transient Loss of Consciousness: A Case Report From Yemen.
Article in Clinical medicine insights. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Miller-Fisher syndrome (MFS) is a rare variant of Guillain-Barré syndrome (GBS), characterized by the classic triad of ataxia, areflexia, and ophthalmoplegia. Atypical presentations involving severe headache and transient loss of consciousness (LOC) are extremely rare, posing a significant diagnostic challenge. Case presentation: We present a 38-year-old Yemeni female with hypertension, type II diabetes mellitus, and recurrent deep vein thrombosis, with no history of recent infection. She presented with an acute, severe headache lasting three days, followed by transient LOC. By the fourth day, the classic MFS triad emerged. In a resource-limited setting, diagnosis was based on the clinical triad and evidence of demyelinating polyneuropathy on nerve conduction studies (NCS), in the absence of anti-GQ1b antibody testing and normal brain neuroimaging. After receiving intravenous immunoglobulin (IVIG), the headache resolved significantly by the third dose. The patient showed improvement in ophthalmoplegia and ptosis, achieving complete neurological recovery within two months. Conclusion: Acute severe headache and transient LOC can be an early, atypical manifestation of MFS. The clinical triad and electrophysiology findings remain the cornerstones of diagnosis when antibody testing is unavailable. Early intervention with IVIG led to a successful outcome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.